News
TRRI
0.0003
NaN%
--
Weekly Report: what happened at TRRI last week (1215-1219)?
Weekly Report · 12/22 10:22
Weekly Report: what happened at TRRI last week (1208-1212)?
Weekly Report · 12/15 10:29
Weekly Report: what happened at TRRI last week (1201-1205)?
Weekly Report · 12/08 10:28
Weekly Report: what happened at TRRI last week (1124-1128)?
Weekly Report · 12/01 10:23
Weekly Report: what happened at TRRI last week (1117-1121)?
Weekly Report · 11/24 10:28
Weekly Report: what happened at TRRI last week (1110-1114)?
Weekly Report · 11/17 10:29
Weekly Report: what happened at TRRI last week (1103-1107)?
Weekly Report · 11/10 10:26
Weekly Report: what happened at TRRI last week (1027-1031)?
Weekly Report · 11/03 10:26
Weekly Report: what happened at TRRI last week (1020-1024)?
Weekly Report · 10/27 10:30
Weekly Report: what happened at TRRI last week (1013-1017)?
Weekly Report · 10/20 10:26
Weekly Report: what happened at TRRI last week (1006-1010)?
Weekly Report · 10/13 10:29
Weekly Report: what happened at TRRI last week (0929-1003)?
Weekly Report · 10/06 10:25
Weekly Report: what happened at TRRI last week (0922-0926)?
Weekly Report · 09/29 10:27
Weekly Report: what happened at TRRI last week (0915-0919)?
Weekly Report · 09/22 10:27
Weekly Report: what happened at TRRI last week (0908-0912)?
Weekly Report · 09/15 09:51
Weekly Report: what happened at TRRI last week (0901-0905)?
Weekly Report · 09/08 09:52
Weekly Report: what happened at TRRI last week (0825-0829)?
Weekly Report · 09/01 09:50
Weekly Report: what happened at TRRI last week (0818-0822)?
Weekly Report · 08/25 09:54
Weekly Report: what happened at TRRI last week (0811-0815)?
Weekly Report · 08/18 09:51
Weekly Report: what happened at TRRI last week (0804-0808)?
Weekly Report · 08/11 09:54
More
Webull provides a variety of real-time TRRI stock news. You can receive the latest news about Trinity Resource through multiple platforms. This information may help you make smarter investment decisions.
About TRRI
Alzex Neuropharma Inc. is a biopharmaceutical company. The Company is engaged in research and development targeting treatments of brain diseases. It is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.